PTCT R&D to Revenue
Ptc Therapeutics Inc · R&D to Revenue
PTCT R&D to Revenue
Latest reported27.50%period ending
PTCT Quarterly R&D/Revenue (133.01% → 27.50%)
Latest values, visible window
High-resolution chart · PNG
PTCT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 27.502% | |
| 37.0107% | |
| 80.8419% | |
| 47.4667% | |
| 63.167% | |
| 9.2657% | |
| 58.5302% | |
| 82.0241% | |
| 70.7907% | |
| 55.2685% | |
| 39.5215% | |
| 83.5361% | |
| 86.935% | |
| 88.539% | |
| 112.7124% | |
| 76.2052% | |
| 95.008% | |
| 94.1796% | |
| 90.6887% | |
| 94.3075% | |
| 107.5474% | |
| 114.0501% | |
| 99.2841% | |
| 78.543% | |
| 234.619% | |
| 132.0075% | |
| 84.835% | |
| 88.3219% | |
| 70.1328% | |
| 98.102% | |
| 62.136% | |
| 101.4499% | |
| 47.4332% | |
| 55.9434% | |
| 37.4651% | |
| 71.7368% | |
| 64.2905% | |
| 103.0738% | |
| 103.2551% | |
| 136.5875% | |
| 184.3984% | |
| 166.1762% | |
| 275.2317% | |
| 313.4848% | |
| 442.6822% | |
| 516.7006% | |
| 231.6066% | |
| 2,354.4542% | |
| 1,291.4669% | |
| 173.7072% | |
| 382.1111% | |
| 89.8471% | |
| 250.7256% | |
| 185.3846% | |
| 159.6693% | |
| 173.2069% | |
| 196.54% | |
| 133.0124% |